Breast cancer, version 3.2013: featured updates to the NCCN guidelines.


Journal Article

These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.

Full Text

Duke Authors

Cited Authors

  • Theriault, RL; Carlson, RW; Allred, C; Anderson, BO; Burstein, HJ; Edge, SB; Farrar, WB; Forero, A; Giordano, SH; Goldstein, LJ; Gradishar, WJ; Hayes, DF; Hudis, CA; Isakoff, SJ; Ljung, B-ME; Mankoff, DA; Marcom, PK; Mayer, IA; McCormick, B; Pierce, LJ; Reed, EC; Schwartzberg, LS; Smith, ML; Soliman, H; Somlo, G; Ward, JH; Wolff, AC; Zellars, R; Shead, DA; Kumar, R; National Comprehensive Cancer Network,

Published Date

  • July 2013

Published In

Volume / Issue

  • 11 / 7

Start / End Page

  • 753 - 760

PubMed ID

  • 23847214

Pubmed Central ID

  • 23847214

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0098


  • eng

Conference Location

  • United States